BC
BSX icon

Brookfield Corp’s Boston Scientific BSX Stock Holding History

Brookfield Corp’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-516,454
Closed -$27.9M – 180
2023
Q2 		$27.9M Buy
516,454
+301,484
+140% +$15.7M 0.11% 69
2023
Q1 		$10.8M Sell
214,970
-199,290
-48% -$9.39M 0.04% 159
2022
Q4 		$19.2M Buy
414,260
+49,696
+14% +$2.15M 0.07% 93
2022
Q3 		$14.1M Buy
+364,564
New +$14.6M 0.05% 119
2021
Q4 		– Sell
-182,764
Closed -$7.93M – 643
2021
Q3 		$7.93M Buy
182,764
+117,982
+182% +$5.22M 0.03% 162
2021
Q2 		$2.77M Buy
+64,782
New +$2.73M 0.01% 303

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brookfield Corp's BSX Position: Q3 2023 in Review

Brookfield Corp sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 516,454 shares — an estimated $27.9M sold.

Brookfield Corp first reported a position in BSX in Q2 2021 and held it in 6 quarters. The position peaked at $27.9M in Q2 2023. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Brookfield Corp reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 516,454 Boston Scientific shares in Q3 2023, an estimated $27.9M.
  • Brookfield Corp first reported a position in Boston Scientific in Q2 2021 and held it in 6 quarters.
  • Brookfield Corp's Boston Scientific position peaked at $27.9M in Q2 2023.
  • 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.